USD 1.83 Billion
Carcinoembryonic Antigen Market Size, Share, Growth Analysis, By Test type(Molecular Tests, Serology Tests), By Application(Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer), By End use industry(Hospitals, Laboratories, Others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2233 |
Region:
Global |
Published Date: June, 2024
Pages:
219
|Tables:
92
|Figures:
76
Carcinoembryonic Antigen Market Insights
Global Carcinoembryonic Antigen Market size was valued at USD 1.83 Billion in 2022 and is poised to grow from USD 1.98 Billion in 2023 to USD 2.63 Billion by 2031, at a CAGR of 4.10% during the forecast period (2024-2031)
The global Carcinoembryonic Antigen (CEA) market has been witnessing top notch increase due to increasing incidence of most cancers, specifically colorectal cancer, that's one of the main applications of CEA testing. The market is characterised by a developing emphasis on early cancer detection and monitoring, main to an augmented demand for tumor markers like CEA. The escalating prevalence of diverse cancers worldwide, specially colorectal most cancers, has fueled the demand for powerful diagnostic gear. CEA, being a reliable tumor marker, is witnessing extended adoption in recurring most cancers screenings.
Additionally, Ongoing improvements in diagnostic technologies, which includes immunoassays and biomarker discovery strategies, contribute to the overall growth of the CEA marketplace. These innovations beautify the accuracy and performance of CEA testing. Despite the benefits of CEA checking out, cost issues remain a big challenge, mainly in areas with limited healthcare budgets. This thing may additionally preclude market growth, particularly in developing economies.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Colorectal Cancer Diagnosis
Fastest Growth
Colorectal Cancer Diagnosis
Growth Rate
4.10% CAGR
Carcinoembryonic Antigen Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Carcinoembryonic Antigen Market Segmental Analysis
The global carcinoembryonic antigen market is segmented based on test type, application, end use industry, and region. Based on test type, the market is segmented into Molecular Tests, and Serology Tests. Based on application, the market is segmented into Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer, Thyroid Cancer, Others. Based on end use industry, the market is segmented into Hospitals, Laboratories, and Others. Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Analysis by Technology Type
Colorectal Cancer Diagnosis is in all likelihood to be the dominant application phase. Colorectal cancer has a significant international occurrence, and CEA is extensively used as a tumor marker for colorectal cancer diagnosis and monitoring. The demand for correct and early detection of colorectal cancer is a key driving force for the dominance of this application phase.
The fastest-developing software phase could be Pancreatic Cancer Diagnosis. Pancreatic cancer is known for its aggressive nature and regularly overdue-stage diagnosis. As cognizance of pancreatic cancer will increase and diagnostic technology enhance, the demand for CEA testing in pancreatic cancer diagnosis can also grow swiftly. Early detection is crucial for powerful treatment, driving the adoption of CEA testing in this segment.
Analysis by Test type
The Enzyme-Linked Immunosorbent Assay (ELISA) is in all likelihood to be the dominant test type. ELISA is a widely used and properly-installed method for detecting and quantifying CEA tiers inside the blood. It offers high sensitivity and specificity, making it a desired technique for CEA testing in numerous scientific settings.
Immunohistochemistry (IHC) will be the quickest-developing check kind. Immunohistochemistry involves the use of antibodies to locate the presence and distribution of CEA in tissue samples. The growth in call for IHC can be driven by improvements in pathology strategies, expanded understanding of cancer biology, and the want for unique localization of CEA in tumor tissues.
Carcinoembryonic Antigen Market By Application
To get detailed analysis on other segments, Request For Free Sample Report
Carcinoembryonic Antigen Market Regional Insights
North America is probably to dominate the CEA marketplace. North America has a tremendously high incidence of colorectal cancer, that's a key utility for CEA testing. The vicinity's ageing population and way of life factors contribute to the prevalence of colorectal cancer. The properly-hooked up healthcare infrastructure in North America supports the adoption of superior diagnostic technology, which includes CEA checking out.
Asia-Pacific is in all likelihood to be the quickest-growing vicinity. The Asia-Pacific region is experiencing a growing incidence of most cancers, together with colorectal cancer. As consciousness of approximately most cancers screening grows, there is a growing call for reliable tumor markers such as CEA. Many countries in Asia-Pacific are investing in healthcare infrastructure and technologies. This investment is probably to help the adoption of superior diagnostic tools, which includes CEA testing, within the area.
Carcinoembryonic Antigen Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Carcinoembryonic Antigen Market Dynamics
Drivers
Increasing Incidence Of Cancer, Particularly Colorectal Cancer
- The growing incidence of most cancers, mainly colorectal cancers, has substantially augmented the call for dependable tumor markers like CEA. Early cancer detection and tracking, facilitated by using CEA checking out, are crucial factors using its adoption.
Restraints
High Cost Constraints Associated With CEA Testing
- One of the main marketplace restraints is the price constraints related to CEA testing. Affordability stays a crucial issue, particularly in areas with constrained healthcare budgets, hindering big accessibility and adoption. Moreover, the marketplace contends with the supply of opportunity diagnostic tools and techniques, along with imaging modalities and liquid biopsy, which may additionally divert attention and sources from special reliance on CEA testing.
Request Free Customization of this report to help us to meet your business objectives.
Carcinoembryonic Antigen Market Competitive Landscape
The aggressive surroundings of the Carcinoembryonic Antigen marketplace is dynamic and is characterized by the presence of numerous key players actively shaping the enterprise dynamics. The enterprise leaders are continuously engaged in studies and improvement sports, aiming to innovate and introduce superior CEA checking out answers. Collaborations and strategic partnerships within the healthcare surroundings are not unusual techniques, fostering synergies for product improvement and market growth.
Top Player’s Company Profiles
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthcare
- Beckman Coulter
- Ortho Clinical Diagnostics
- Sysmex Corporation
- Alere Inc.
- bioMérieux
- DiaSorin SpA
- Quidel Corporation
- Thermo Fisher Scientific
- Hytest Ltd.
- Luminex Corporation
- Fujifilm Holdings Corporation
- Danaher Corporation
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- Eurofins Scientific
- Bio-Techne Corporation
Recent Developments
- December 2023: Sanofi is halting the worldwide scientific development initiative for tusamitamab ravtansine. This choice stems from the outcomes of a predetermined intervening time analysis of the Phase three CARMEN-LC03 trial, which assesses tusamitamab ravtansine as a monotherapy in opposition to docetaxel in previously treated patients with metastatic non-squamous non-small cellular lung cancer (NSCLC).
- In May 2022, the University of Texas MD Anderson Cancer Center and Virogin Biotech announced a strategic collaboration to accelerate the development of investigational treatments, including oncolytic viruses and immunotherapies, for patients with advanced cancers.
Carcinoembryonic Antigen Key Market Trends
- Rising Integration Of Advanced Technologies In Cea Testing Methodologies: The growing integration of superior technology in CEA testing methodologies. Continuous improvements in diagnostic technology, including the utility of novel immunoassays and improvements in biomarker discovery, are improving the precision and performance of CEA. Another tremendous fashion is the increasing scope of CEA packages past conventional most cancers diagnostics.
Carcinoembryonic Antigen Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global Carcinoembryonic Antigen marketplace evaluation reveals a dynamic marketplace with some of standout tendencies and problems. The marketplace is propelled by using the growing prevalence of cancer, in particular colorectal most cancers, driving demand for correct diagnostic tools. However, fee constraints and competition from alternative diagnostic techniques pose restraints. In product kind analysis, Enzyme-Linked Immunosorbent Assay (ELISA) dominates because of its reliability. North America leads regionally, supported with the aid of superior healthcare infrastructure. A key fashion is the industry's recognition of personalized remedies. Overall, the marketplace reveals ability to increase, pushed by using technological advancements and increasing cognizance of early most cancers detection.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.83 Billion |
| Market size value in 2031 | USD 2.63 Billion |
| Growth Rate | 4.10% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Carcinoembryonic Antigen Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Carcinoembryonic Antigen Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Carcinoembryonic Antigen Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Carcinoembryonic Antigen Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Carcinoembryonic Antigen Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Carcinoembryonic Antigen Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
